It is remarkable that the interaction between HLA-G and ILT2 or ILT4 in tumor cells results in tumor progression, while binding of HLA-G to ILT2 or ILT4 expressed by immune cells results in suppression of these immune cells. The gene discussed is LILRB1; the disease is neoplasm.